Claio
医療助手 · 4.2K 月間訪問数
Claioは、医療専門家向けに設計されたAIスクライブで、臨床文書作成を効率化します。患者の診察をリアルタイムで文字起こしし、正確な臨床ノートと請求コードを即座に生成します。既存のEHRにコピー＆ペーストでシームレスに統合され、HIPAA準拠を保証し、管理負担を軽減します。
製品概要
Claio 製品概要
Claioは、医療専門家向けに設計されたAIスクライブで、臨床文書作成を効率化します。患者の診察をリアルタイムで文字起こしし、正確な臨床ノートと請求コードを即座に生成します。既存のEHRにコピー＆ペーストでシームレスに統合され、HIPAA準拠を保証し、管理負担を軽減します。
Preview
ScribeMD 製品概要
ScribeMDは、医療専門家向けに設計されたHIPAA準拠のAI医療書記です。患者との対話を聞き取り、文字起こしし、構造化された文書を生成することで、臨床ノートの作成を自動化します。これにより、医師は管理業務を削減し、患者一人当たりの時間を大幅に節約し、より患者ケアに集中できます。
Preview
Detailed feature comparison
| Feature | Claio | ScribeMD |
|---|---|---|
| 主要カテゴリー | 医療助手 | 医療文書 |
| 追加日 | 2025-10-22 | 2025-08-10 |
| 価格 | フリーミアム | 有料 |
| 公式サイト | www.claio.ai | www.scribemd.ai |
| 製品タイプ | ウェブサイト | ウェブサイト |
| Performance data | ||
| ユーザー評価 | 未確認 | 未確認 |
| コメント | 0 | 0 |
| 月間訪問数 | 4.2K | 4.5K |
| 月間成長率 | -68.1% | 21.4% |
| お気に入り | 131 | 104 |
| Details | 詳細を見る | 詳細を見る |
Claio vs ScribeMD monthly traffic
Compare Claio and ScribeMD by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the Claio vs ScribeMD monthly traffic comparison, Claio currently shows 4.2K visits and ScribeMD shows 4.5K; the two products have similar visible traffic, an absolute difference of about 364 visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
Claio monthly traffic:
Latest traffic
月間訪問数
4.2K
平均滞在時間
6:49
訪問あたりページ数
2.85
直帰率
39.84%
Data updated 2026-06-15
Monthly traffic trend
- 2025/9: 842 月間訪問数
- 2026/1: 0 月間訪問数
- 2026/2: 1.2K 月間訪問数
- 2026/3: 4.4K 月間訪問数
- 2026/4: 13.1K 月間訪問数
- 2026/5: 4.2K 月間訪問数
主要地域
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 100% | 4.2K |
流入元
| Source type | Percentage | Traffic |
|---|---|---|
| ダイレクト | 100% | 4.2K |
検索キーワード
claio
ScribeMD monthly traffic:
Latest traffic
月間訪問数
4.5K
平均滞在時間
0:24
訪問あたりページ数
1.77
直帰率
39.06%
Data updated 2026-06-11
Monthly traffic trend
- 2025/9: 4.9K 月間訪問数
- 2026/1: 6K 月間訪問数
- 2026/2: 4.2K 月間訪問数
- 2026/3: 2K 月間訪問数
- 2026/4: 3.7K 月間訪問数
- 2026/5: 4.5K 月間訪問数
主要地域
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 84.66% | 3.8K |
| 🇪🇸Spain | 14.21% | 644 |
| 🇮🇳India | 1.13% | 51 |
検索キーワード
ai healthcare scribescribe mdscribemdscribemd - ai medical scribe:scribemd – ai medical scribe
Traffic-based selection guidance: The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Usage comparison
Compare the core capabilities of Claio and ScribeMD
Claio Core features
医療文書
文字起こし
医療助手
請求とコーディング
臨床記録
ScribeMD Core features
医療文書
文字起こし
自動化
Use cases
Claio Use cases
医療AI
HIPAA準拠
医療転写
AI書記
バーンアウトの軽減
診療記録
電子カルテ連携
医療生産性
医療コーディング
医療ディクテーション
患者記録
実行効率
音声テキスト変換
ScribeMD Use cases
医療AI
HIPAA準拠
医療転写
臨床文書
医師生産性
EMR自動化
医療クラーク
患者記録
音声テキスト変換
Best suited roles
Claio Best suited roles
臨床医
歯科医
栄養士
医療従事者
医師
理学療法士
セラピスト
獣医
ScribeMD Best suited roles
確認済みデータなし
Claio vs ScribeMD：In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth Claio vs ScribeMD comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. Claio is primarily listed under “医療助手”, while ScribeMD is primarily listed under “医療文書”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (Claio: 医療助手; ScribeMD: 医療文書); Pricing (Claio: Freemium; ScribeMD: Paid); Monthly visits (Claio: 4.2K; ScribeMD: 4.5K); Monthly growth (Claio: -68.1%; ScribeMD: 21.4%); Favorites (Claio: 131; ScribeMD: 104). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the Claio vs ScribeMD monthly traffic comparison, Claio currently shows 4.2K visits and ScribeMD shows 4.5K; the two products have similar visible traffic, an absolute difference of about 364 visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Product positioning, use cases, and roles
Claio and ScribeMD currently overlap in shared categories: 医療文書、文字起こし; shared tags: 医療AI、HIPAA準拠、医療転写. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
Claio's unique categories/tags are 医療助手、請求とコーディング、臨床記録、AI書記、バーンアウトの軽減、診療記録、電子カルテ連携、医療生産性; ScribeMD's are 自動化、臨床文書、医師生産性、EMR自動化、医療クラーク、患者記録、音声テキスト変換. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
Claio has no verified rating, 0 comments, 131 favorites, and 127 likes；ScribeMD has no verified rating, 0 comments, 104 favorites, and 124 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate Claio first
Put Claio on the priority trial list when the task aligns with “医療助手” and especially 医療助手、請求とコーディング、臨床記録、AI書記、バーンアウトの軽減、診療記録, or the users include 臨床医、歯科医、栄養士、医療従事者. This follows recorded positioning and does not imply unlisted capabilities are absent.
Claio also currently records: pricing is freemium, product type is website, 4.2K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate ScribeMD first
Put ScribeMD on the priority trial list when the task aligns with “医療文書” and especially 自動化、臨床文書、医師生産性、EMR自動化、医療クラーク、患者記録. This follows recorded positioning and does not imply unlisted capabilities are absent.
ScribeMD also currently records: pricing is paid, product type is website, 4.5K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in Claio and ScribeMD, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.
比較 FAQ
How should I choose between Claio and ScribeMD?
Compare positioning, pricing, taxonomy, and traffic maturity, then verify the latest details on each official website.
Where does this comparison data come from?
The factual baseline is derived from product, taxonomy, traffic, and community data. Reviewed editorial conclusions show their source and verification date.
What do unknown fields mean?
Unknown means there is not enough reliable evidence; the page does not fill gaps with assumptions.